https://amnealbiosciences.com › portfolio
赞助Bevacizumab inhibits angiogenesis by binding to vascular endothelial growth factor (VEGF). We offer extraordinary value for patients, providers, and payers.
20+ Years · 3+ Biosimilars · For HCPs · Amneal Pharmaceuticals